[HTML][HTML] Direct-Acting Oral Anticoagulants in patients at extremes of body weight: a review of pharmacological considerations and clinical implications
Patients at extremes of body weight are underrepresented in randomized controlled trials of
direct-acting oral anticoagulants (DOACs). Therefore, their optimal anticoagulant treatment …
direct-acting oral anticoagulants (DOACs). Therefore, their optimal anticoagulant treatment …
[HTML][HTML] Direct-Acting Oral Anticoagulants in patients at extremes of body weight: a review of pharmacological considerations and clinical implications
R Talerico, R Pola, FA Klok… - TH Open: Companion …, 2024 - ncbi.nlm.nih.gov
Direct-Acting Oral Anticoagulants in patients at extremes of body weight: a review of
pharmacological considerations and clinical implications - PMC Back to Top Skip to main content …
pharmacological considerations and clinical implications - PMC Back to Top Skip to main content …
Direct-Acting Oral Anticoagulants in patients at extremes of body weight: a review of pharmacological considerations and clinical implications
R Talerico, R Pola, FA Klok… - TH open: companion …, 2024 - pubmed.ncbi.nlm.nih.gov
Patients at extremes of body weight are underrepresented in randomized controlled trials of
direct-acting oral anticoagulants (DOACs). Therefore, their optimal anticoagulant treatment …
direct-acting oral anticoagulants (DOACs). Therefore, their optimal anticoagulant treatment …
Direct-Acting Oral Anticoagulants in patients at extremes of body weight: a review of pharmacological considerations and clinical implications
R Talerico, R Pola, F Klok, M Huisman - TH Open: Companion …, 2024 - europepmc.org
Direct-Acting Oral Anticoagulants in patients at extremes of body weight: a review of
pharmacological considerations and clinical implications - Abstract - Europe PMC Sign in …
pharmacological considerations and clinical implications - Abstract - Europe PMC Sign in …
Direct-Acting Oral Anticoagulants in patients at extremes of body weight: a review of pharmacological considerations and clinical implications.
R Talerico, R Pola, FA Klok… - TH Open: Companion …, 2024 - europepmc.org
Patients at extremes of body weight are underrepresented in randomized controlled trials of
direct-acting oral anticoagulants (DOACs). Therefore, their optimal anticoagulant treatment …
direct-acting oral anticoagulants (DOACs). Therefore, their optimal anticoagulant treatment …